Sodium MRI and the Assessment of Irreversible Tissue Damage During Hyper-Acute Stroke

Translational Stroke Research

Volumn 3, Issue 2, 2012, Pages 236-245

  Boada, Fernando E ^a   Qian, Yongxian ^a   Nemoto, Edwin ^b   Jovin, Tudor ^a   Jungreis, Charles ^c   Jones, S C ^d   Weimer, Jonathan ^a   Lee, Vincent ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d ALLEGHENY GENERAL HOSPITAL   (United States)

Author keywords

Acute ischemia; MRI; Sodium; Stroke; Tissue viability

Indexed keywords

ALTEPLASE; SODIUM;

BRAIN ISCHEMIA; HUMAN; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; SODIUM MAGNETIC RESONANCE IMAGING; STROKE; TISSUE LEVEL; TISSUE SODIUM CONCENTRATION;

EID: 84861681898     PISSN: 18684483     EISSN: 1868601X     Source Type: Journal    
DOI: 10.1007/s12975-012-0168-7     Document Type: Review

References (104)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995; 333(24): 1581-7.
2. LeBihan D, et al. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology. 1986; 161: 401-7.
3. Dardzinski BJ, et al. Apparent diffusion coefficient mapping of experimental focal cerebral ischemia using diffusion-weighted echo-planar imaging. Magn Reson Med. 1993; 30: 318-25.
4. Benveniste H, Hedlund L, Johnson G. Mechanism of detection of acute cerebral ischemia in rats by diffusion-weighted magnetic resonance microscopy. Stroke. 1992; 23: 746-54.
5. de Crespigny AJ, Tsuura M, Moseley ME, Kucharczyk J. Perfusion and diffusion MR imaging of thromboembolic stroke. J Magn Reson Imaging. 1993; 3(5): 746-54.
6. Fisher M. Diffusion and perfusion imaging for acute stroke. Surg Neurol. 1995; 43(6): 606-9.
7. Hasegawa Y, Fisher M, Latour L, Dardzinski B, Sotak C. MRI diffusion mapping of reversible and irreversible ischemic injury in focal brain ischemia. Neurology. 1994; 44: 1484-90.
8. Hossmann K, Hoehn-Berlage M. Diffusion and perfusion MR imaging of cerebral ischemia. Cerebrovasc Brain Metab Rev. 1995; 7(3): 187-217.
9. Kucharczyk J, Mintorovitch J, Asgari H, Tsuura M, Moseley M. In vivo diffusion-perfusion magnetic resonance imaging of acute cerebral ischemia. Can J Physiol Pharmacol. 1991; 69(11): 1719-25.
10. Kucharczyk J, Mintorovitch J, Asgari HS, Moseley M. Diffusion/perfusion MR imaging of acute cerebral ischemia. Magn Reson Med. 1991; 19(2): 311-5.
11. Minematsu K, Fisher M, Li L, Sotak CH. Diffusion and perfusion magnetic resonance imaging studies to evaluate a noncompetitive N-methyl-d-aspartate antagonist and reperfusion in experimental stroke in rats. Stroke. 1993; 24(12): 2074-81.
12. Minematsu K, Li L, Sotak C, Davis M, Fisher M. Reversible focal ischemia injury demonstrated by diffusion-weighted magnetic resonance imaging in rats. Stroke. 1992; 23(9): 1304-11.
13. Mintorovitch J, et al. Comparison of diffusion and T2-weighted MRI for the early detection of cerebral ischemia and reperfusion in rats. Magn Reson Med. 1991; 18: 39-50.
14. Moseley M, Mintorovitch J, Cohen Y, et al. Early detection of ischemic injury: comparison of spectroscopy, diffusion-, T2-, and magnetic susceptibility-weighted MRI in cats. Acta Neurochirurgica Supp. 1990; 51: 207-9.
15. Moseley M, Cohen Y, Mintorovitch J, et al. Early detection of regional cerebral ischemia in cats: comparison of diffusion- and T2-weighted MRI and spectroscopy. Magn Reson Med. 1990; 14: 330-46.
16. Moseley M, et al. Diffusion-weighted MR imaging of acute stroke: correlation with T2-weighted and magnetic susceptibility-enhanced MR imaging in cats. AJNR. 1990; 11: 423-9.
17. Moseley ME, Wendland MF, Kucharczyk J. Magnetic resonance imaging of diffusion and perfusion. Top Magn Reson Imaging. 1991; 3(3): 50-67.
18. Perez-Trepichio A, et al. Sensitivity of magnetic resonance diffusion-weighted imaging and regional relationship between the apparent diffusion coefficient and cerebral blood flow in rat focal cerebral ischemia. Stroke. 1995; 26: 667-75.
19. Warach S, Dashe J, Edelman R. Clinical outcome in ischemic stroke predicted by early diffusion-weighted and perfusion magnetic resonance imaging: a preliminary analysis. J Cereb Blood Flow Metab. 1996; 16: 53-9.
20. Albers GW. Expanding the window for thrombolytic therapy in acute stroke. The potential role of acute MRI for patient selection. Stroke. 1999; 30(10): 2230-7.
21. Albers GW. Advances in intravenous thrombolytic therapy for treatment of acute stroke. Neurology. 2001; 57 Suppl 2: S77-81.
22. Luypaert R, Boujraf S, Sourbron S, Osteaux M. Diffusion and perfusion MRI: basic physics. Eur J Radiol. 2001; 38(1): 19-27.
23. Muller TB, et al. Perfusion and diffusion-weighted MR imaging for in vivo evaluation of treatment with U74389G in a rat stroke model. Stroke. 1995; 26(8): 1453-8.
24. Neumann-Haefelin T, et al. Diffusion- and perfusion-weighted MRI. The DWI/PWI mismatch region in acute stroke. Stroke. 1999; 30(8): 1591-7.
25. Ostergaard L, et al. Combined diffusion-weighted and perfusion-weighted flow heterogeneity magnetic resonance imaging in acute stroke. Stroke. 2000; 31(5): 1097-103.
26. Ozsunar Y, Sorensen AG. Diffusion- and perfusion-weighted magnetic resonance imaging in human acute ischemic stroke: technical considerations. Top Magn Reson Imaging. 2000; 11(5): 259-72.
27. Ueda T, Yuh WT, Taoka T. Clinical application of perfusion and diffusion MR imaging in acute ischemic stroke. J Magn Reson Imaging. 1999; 10(3): 305-9.
28. Wityk RJ, et al. Diffusion- and perfusion-weighted brain magnetic resonance imaging in patients with neurologic complications after cardiac surgery. Arch Neurol. 2001; 58(4): 571-6.
29. Wu O, et al. Predicting tissue outcome in acute human cerebral ischemia using combined diffusion- and perfusion-weighted MR imaging. Stroke. 2001; 32(4): 933-42.
30. Yenari MA, et al. Diffusion- and perfusion-weighted magnetic resonance imaging of focal cerebral ischemia and cortical spreading depression under conditions of mild hypothermia. Brain Res. 2000; 885(2): 208-19.
31. Kidwell C, et al. Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging. Ann Neurol. 2000; 47(4): 462-9.
32. Krueger K, et al. Late resolution of diffusion-weighted MRI changes in a patient with prolonged reversible ischemic neurological deficit after thrombolytic therapy. Stroke. 2000; 31(11): 2715-8.
33. Betz A, Keep R, Beer M, Ren X. Blood-brain barrier permeability and brain concentration of sodium, potassium, and chloride during focal ischemia. J Cereb Blood Flow Metab. 1994; 14(1): 29-37.
34. Hu W, Kharlamov A, Wang Y, Perez-Trepichio AD, Jones SC. Directed sampling for electrolyte analysis and water content of micro-punch samples shows large differences between normal and ischemic rat brain cortex. Brain Res. 2000; 868(2): 370-5.
35. Wang Y, et al. Brain tissue is a ticking clock telling time after arterial occlusion in rat focal cerebral ischemia. Stroke. 2000; 31: 1386-92.
36. Yang G, Chen S, Kinouchi H, Chan P, Weinstein P. Edema, cation content, and ATPase activity after middle cerebral artery occlusion in rats. Stroke. 1992; 23: 1331-6.
37. Ito U, Ohno K, Nakamura R, Suganuma F, Inaba Y. Brain edema during ischemia and after restoration of blood flow. Stroke. 1979; 10(5): 542-7.
38. Memezawa H, Smith M, Siesjo B. Penumbral tissues salvaged by reperfusion following middle cerebral artery occlusion in rats. Stroke. 1992; 23(4): 552-9.
39. Hossmann K, Schuier F. Experimental brain infarcts in cats I. Pathophysiological observations. Stroke. 1980; 11(6): 583-92.
40. Schuier F, Hossmann K. Experimental brain infarcts in cats. II. Ischemic brain edema. Stroke. 1980; 11: 593-601.
41. Asano T, Gotoh O, Koide T, Takakura K. Ischemic brain edema following occlusion of the middle cerebral artery in the rat. Part II: alteration of the eicosanoid synthesis profile of brain microvessels. Stroke. 1985; 16(1): 110-3.
42. Gotoh O, Asano T, Koide T, Takakura K. Ischemic brain edema following occlusion of the middle cerebral artery in the rat I: the time courses of the brain water, sodium and potassium contents and blood-brain barrier permeability to 125I-albumin. Stroke. 1985; 16(1): 101-9.
43. Gotoh O, Asano T, Koide T, Takakura K. Ischemic brain edema following occlusion of the middle cerebral artery in the rat II: alteration of the eicosanoid syntheis profile of brain microvessels. Stroke. 1985; 16(1): 110-3.
44. Hossmann K, Sakai S, Zimmermann V. Cation activities in reversible ischemia of the cat brain. Stroke. 1977; 8(1): 77-81.
45. Menzies S, Betz A, Hoff J. Contributions of ions and albumin to the formation and resolution of ischemic brain edema. J Neurosurgery. 1993; 78: 257-66.
46. Hatashita S, Hoff J. Brain edema and cerebrovascular permeability during cerebral ischemia in rats. Stroke. 1990; 21: 582-8.
47. Hatashita S, Hoff JT, Salamat SM. An osmotic gradient in ischemic brain edema. Adv Neurol. 1990; 52: 85-92.
48. O'Brien M, Jordan M, Waltz A. Ischemic cerebral edema and the blood-brain barrier. Arch Neurol. 1974; 30: 461-5.
49. O'Brien MD, Jordan MM, Waltz AG. Ischemic cerebral edema and the blood-brain barrier. Distributions of pertechnetate, albumin, sodium, and antipyrine in brains of cats after occlusion of the middle cerebral artery. Arch Neurol. 1974; 30(6): 461-5.
50. Siegel B, Studer R, Potchen E. Brain 22 Na uptake in experimental cerebral microembolism. J Neurosurg. 1973; 38: 739-42.
51. Young W, Rappaport Z, Chalif D, Flamm E. Regional brain sodium, potassium, and water changes in the rat middle cerebral artery occlusion model of ischemia. Stroke. 1987; 18: 751-9.
52. Fisher M, Sotak CH, Minematsu K, Li L. New magnetic resonance techniques for evaluating cerebrovascular disease. Ann Neurol. 1992; 32(2): 115-22.
53. Yang G, Betz A. Reperfusion-induced injury to the blood-brain barrier after middle cerebral artery occlusion in rats. Stroke. 1994; 25(8): 1658-65.
54. Little JR. Treatment of acute focal cerebral ischemia with intermittent, low dose mannitol. Neurosurgery. 1979; 5(6): 687-91.
55. Kaplan B, Brint S, Tanabe J, et al. Temporal thresholds for neocortical infarction in rats subjected to reversible focal cerebral ischemia. Stroke. 1991; 22: 1032-9.
56. Marcoux F, Morawetz R, Crowell R, et al. Differential regional vulnerability in transient focal ischemia. Stroke. 1982; 13: 339-46.
57. Jones T, Morawetz R, Crowell R, et al. Thresholds of focal cerebral ischemia in awake monkeys. J Neurosurg. 1981; 54: 773-82.
58. Thulborn KR, Gindin TS, Davis D, Erb P. Comprehensive MR imaging protocol for stroke management: tissue sodium concentration as a measure of tissue viability in nonhuman primate studies and in clinical studies. Radiology. 1999; 213(1): 156-66.
59. Boada FE, et al. Loss of cell ion homeostasis and cell viability in the brain: what sodium MRI can tell us. Curr Top Dev Biol. 2005; 70: 77-101.
60. Hussain MS, et al. Sodium imaging intensity increases with time after human ischemic stroke. Ann Neurol. 2009; 66(1): 55-62.
61. Thulborn K, Gidin T, Davis D, Erb P. Comprehensive MRI protocol for stroke management: tissue sodium concentration as a measure of tissue viability in a non-human primate model and clinical studies. Radiology. 1999; 139: 26-34.
62. LaVerde G, Nemoto E, Jungreis CA, Tanase C, Boada FE. Serial triple quantum sodium MRI during non-human primate focal brain ischemia. Magn Reson Med. 2007; 57(1): 201-5.
63. Goodman JA, Kroenke CD, Bretthorst GL, Ackerman JJ, Neil JJ. Sodium ion apparent diffusion coefficient in living rat brain. Magn Reson Med. 2005; 53(5): 1040-5.
64. Jones SC, et al. Stroke onset time using sodium MRI in rat focal cerebral ischemia. Stroke. 2006; 37(3): 883-8.
65. Siemkowicz E, Hansen A. Brain extracellular ion composition and EEG activity following 10 Minutes ischemia in normo- and hyperglycemic rats. Stroke. 1981; 12(2): 236-40.
66. Siesjo B. Brain Energy Metabolism. New York: Wiley; 1978.
67. Hilal S, et al. In vivo NMR imaging of sodium-23 in the human head. J Comput Assist Tomogr. 1985; 9(1): 1-7.
68. Boada F, Christensen J, Huang-Hellinger F, Reese T, Thulborn K. Quantitative in vivo tissue sodium concentration maps: the effects of biexponential relaxation. Magn Reson Med. 1994; 32: 219-23.
69. Schuierer G, Ladebeck R, Barfub H, Hentschel D, Huk W. Sodium-23 imaging of supratentorial lesions at 4. 0 T. Magn Reson Med. 1991; 22: 1-9.
70. Shimizu T, Naritomi H, Sawada T. Sequential changes on 23Na MRI after cerebral infarction. Neuroradiology. 1993; 35: 416-9.
71. Kharrazian R, Jakob PM. Dynamics of 23Na during completely balanced steady-state free precession. J Magn Reson. 2006; 179(1): 73-84.
72. Stobbe R, Beaulieu C. Sodium imaging optimization under specific absorption rate constraint. Magn Reson Med. 2008; 59(2): 345-55.
73. Tsang A, et al. Relationship between sodium intensity and perfusion deficits in acute ischemic stroke. J Magn Reson Imaging. 2011; 33(1): 41-7.
74. Boada F, Gillen J, Noll D, Shen G, Thulborn K. Data acquisition and post-processing strategies for fast quantitative sodium imaging. Int J Imaging Syst Technol. 1997; 8: 544-50.
75. Boada F, Gillen J, Shen G, Chang S, Thulborn K. Fast three dimensional sodium imaging. Magn Reson Med. 1997; 37: 706-15.
76. LaVerde GC, Jungreis CA, Nemoto E, Boada FE. Sodium time course using 23Na MRI in reversible focal brain ischemia in the monkey. J Magn Reson Imaging. 2009; 30(1): 219-23.
77. Weber MA, Nagel AM, Jurkat-Rott K, Lehmann-Horn F. Sodium (23Na) MRI detects elevated muscular sodium concentration in Duchenne muscular dystrophy. Neurology. 2011; 77(23): 2017-24.
78. Nagel AM, et al. The potential of relaxation-weighted sodium magnetic resonance imaging as demonstrated on brain tumors. Invest Radiol. 2011; 46(9): 539-47.
79. Konstandin S, Nagel AM, Heiler PM, Schad LR. Two-dimensional radial acquisition technique with density adaption in sodium MRI. Magn Reson Med. 2011; 65(4): 1090-6.
80. Matthies C, Nagel AM, Schad LR, Bachert P. Reduction of B(0) inhomogeneity effects in triple-quantum-filtered sodium imaging. J Magn Reson. 2010; 202(2): 239-44.
81. Nagel AM, et al. Sodium MRI using a density-adapted 3D radial acquisition technique. Magn Reson Med. 2009; 62(6): 1565-73.
82. Qian Y, et al. Sodium imaging of human brain at 7 T with 15-channel array coil. Magn Reson Med. 2012. doi: 10. 1002/mrm. 24192.
83. Madelin G, Chang G, Otazo R, Jerschow A, Regatte RR. Compressed sensing sodium MRI of cartilage at 7T: preliminary study. J Magn Reson. 2012; 214(1): 360-5.
84. Kopp C, et al. (23)Na magnetic resonance imaging of tissue sodium. Hypertension. 2012; 59(1): 167-72.
85. Juras V, et al. Sodium MR imaging of Achilles tendinopathy at 7 T: preliminary results. Radiology. 2012; 262(1): 199-205.
86. Lu A, Atkinson IC, Vaughn JT, Thulborn KR. Impact of gradient timing error on the tissue sodium concentration bioscale measured using flexible twisted projection imaging. J Magn Reson. 2011; 213(1): 176-81.
87. Madelin G, Jerschow A, Regatte RR. Sodium relaxation times in the knee joint in vivo at 7T. NMR Biomed. 2011; 25(4): 530-7.
88. Harrington MG, Chekmenev EY, Schepkin V, Fonteh AN, Arakaki X. Sodium MRI in a rat migraine model and a NEURON simulation study support a role for sodium in migraine. Cephalalgia. 2011; 31(12): 1254-65.
89. Heiler PM, et al. Chemical shift sodium imaging in a mouse model of thromboembolic stroke at 9. 4 T. J Magn Reson Imaging. 2011; 34(4): 935-40.
90. Schepkin VD, et al. In vivo magnetic resonance imaging of sodium and diffusion in rat glioma at 21. 1 T. Magn Reson Med. 2012; 67(4): 1159-66.
91. 23Na sodium MR, and multimodality (PET/CT/MRI) imaging in locally advanced breast cancer. Breast Cancer Res Treat. 2011; 128(1): 119-26.
92. Ouwerkerk R. Sodium MRI. Methods Mol Biol. 2011; 711: 175-201.
93. Allen SP, et al. Phase-sensitive sodium B1 mapping. Magn Reson Med. 2010; 65(4): 1125-30.
94. Madelin G, Lee JS, Inati S, Jerschow A, Regatte RR. Sodium inversion recovery MRI of the knee joint in vivo at 7T. J Magn Reson. 2010; 207(1): 42-52.
95. Staroswiecki E, et al. In vivo sodium imaging of human patellar cartilage with a 3D cones sequence at 3 T and 7 T. J Magn Reson Imaging. 2010; 32(2): 446-51.
96. 0 inhomogeneity-insensitive triple-quantum-filtered sodium imaging using a 12-step phase-cycling scheme. NMR Biomed. 2010; 23(10): 1191-8.
97. Lu A, Atkinson IC, Claiborne TC, Damen FC, Thulborn KR. Quantitative sodium imaging with a flexible twisted projection pulse sequence. Magn Reson Med. 2010; 63(6): 1583-93.
98. Qian Y, Stenger VA, Boada FE. Parallel imaging with 3D TPI trajectory: SNR and acceleration benefits. Magn Reson Imaging. 2008; 27(5): 656-63.
99. Yushmanov VE, et al. Inhomogeneous sodium accumulation in the ischemic core in rat focal cerebral ischemia by 23Na MRI. J Magn Reson Imaging. 2009; 30(1): 18-24.
100. Yushmanov VE, et al. Sodium mapping in focal cerebral ischemia in the rat by quantitative (23)Na MRI. J Magn Reson Imaging. 2009; 29(4): 962-6.
101. Horowitz M, Kassam A, Nemoto E, Arimoto J, Jungreis C. An endovascular primate model for the production of a middle cerebral artery ischemic infarction. Interv Neuroradiol. 2001; 7: 223-8.
102. Jungreis CA, Nemoto E, Boada F, Horowitz MB. Model of reversible cerebral ischemia in a monkey model. AJNR Am J Neuroradiol. 2003; 24(9): 1834-6.
103. Kharlamov A, Kim D, Jones S. Reflective change on unprocessed cryostat brain sections and MAP2 immunoreactivity indicate similar ischemic regions. Soc Neurosci Abstr. 2000; 26.
104. Kharlamov A, et al. MAP2 immunostaining in thick sections for early ischemic stroke infarct volume in non-human primate brain. J Neurosci Methods. 2009; 182(2): 205-10.